Posted by jrbecker on December 28, 2002, at 11:22:33
In reply to Re: Straterra approval. » scoper, posted by viridis on December 28, 2002, at 2:52:55
look for Strattera coming out around the 15th of January. It's actually a NARI, not an SNRI, since it has no effect on the serotonin system. It has a mild affinity to some dopamine subreceptor types as well.
This will be a great adjunct for atypical depressive types as well as any ADHD types with comorbid depressive features. I myself am first in line to my doc to try it. The data looks very promising, especially for subjects with comorbid affect disrders. I have augmented with stimulants for years now to help my atypical symptoms as well as issues with focus. I'm quite confident that Strattera will probably be a better fit for me than the stimulants have been. Check out medscape or strattera.com for more info.
If you're awaiting a good new SNRI, look out for Cymbalta (duloxetine) -- which is also by Lilly --to be released in 3-4 months. It looks to be a fairly good improvement on Effexor.
poster:jrbecker
thread:133458
URL: http://www.dr-bob.org/babble/20021223/msgs/133495.html